Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Aetiology: Searching for schizophrenia's roots

Sixty years after the first schizophrenia drug hit the market, researchers are still struggling to understand and treat the disorder. By Emily Elert.

A biochemical cascade

Dysregulation of glutamate may help explain why people with schizophrenia have too much dopamine in some parts of the brain and too little in others, giving rise to a broad spectrum of symptoms.

Credit: Source: LSE Effective Interventions in Schizophrenia: The Economic Case

Societal costs

In 2012, researchers at the London School of Economics estimated that schizophrenia costs England more than £11.8 billion (US$19.7 billion) each year — nearly £76,00 for each person afflicted

Credit: Source: LSE Effective Interventions in Schizophrenia: The Economic Case

The changing face of schizophrenia

Credit: Source: W. W. Eaton et al. Arch. Gen. Psychiatry 52, 127–134 (1995)

15 years of drug development

The most widely used schizophrenia drugs, atypical antiphsychotics, are effective in treating positive symptoms. But researchers are finding new neural targets to address negative and cognitive symptoms.

Credit: Source: Hugo Geerts, In Silico Biosciences

Schizophrenia slowdown

For the past ten years, clinial trials of schizophrenia treatments have been on a downward trajectory, even though clinial trials in general have been rising.

Credit: Source:
Credit: Source:

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Elert, E. Aetiology: Searching for schizophrenia's roots. Nature 508, S2–S3 (2014).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing